Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- Part I Introduction: definition and classification of the human herpesviruses
- Part II Basic virology and viral gene effects on host cell functions: alphaherpesviruses
- Part II Basic virology and viral gene effects on host cell functions: betaherpesviruses
- Part II Basic virology and viral gene effects on host cell functions: gammaherpesviruses
- Part III Pathogenesis, clinical disease, host response, and epidemiology: HSV-1 and HSV-2
- Part III Pathogenesis, clinical disease, host response, and epidemiology: VZU
- Part III Pathogenesis, clinical disease, host response, and epidemiology: HCMV
- 41 HCMV: pathogenesis and disease consequences
- 42 HCMV: molecular basis of persistence and latency
- 43 HCMV: immunobiology and host response
- 44 HCMV: persistence in the population: epidemiology and transmisson
- 45 HCMV: persistence in the population: potential transplacental transmission
- Part III Pathogenesis, clinical disease, host response, and epidemiology: HHV- 6A, 6B, and 7
- Part III Pathogenesis, clinical disease, host response, and epidemiology: gammaherpesviruses
- Part IV Non-human primate herpesviruses
- Part V Subversion of adaptive immunity
- Part VI Antiviral therapy
- Part VII Vaccines and immunothgerapy
- Part VIII Herpes as therapeutic agents
- Index
- Plate section
- References
44 - HCMV: persistence in the population: epidemiology and transmisson
from Part III - Pathogenesis, clinical disease, host response, and epidemiology: HCMV
Published online by Cambridge University Press: 24 December 2009
- Frontmatter
- Contents
- List of contributors
- Preface
- Part I Introduction: definition and classification of the human herpesviruses
- Part II Basic virology and viral gene effects on host cell functions: alphaherpesviruses
- Part II Basic virology and viral gene effects on host cell functions: betaherpesviruses
- Part II Basic virology and viral gene effects on host cell functions: gammaherpesviruses
- Part III Pathogenesis, clinical disease, host response, and epidemiology: HSV-1 and HSV-2
- Part III Pathogenesis, clinical disease, host response, and epidemiology: VZU
- Part III Pathogenesis, clinical disease, host response, and epidemiology: HCMV
- 41 HCMV: pathogenesis and disease consequences
- 42 HCMV: molecular basis of persistence and latency
- 43 HCMV: immunobiology and host response
- 44 HCMV: persistence in the population: epidemiology and transmisson
- 45 HCMV: persistence in the population: potential transplacental transmission
- Part III Pathogenesis, clinical disease, host response, and epidemiology: HHV- 6A, 6B, and 7
- Part III Pathogenesis, clinical disease, host response, and epidemiology: gammaherpesviruses
- Part IV Non-human primate herpesviruses
- Part V Subversion of adaptive immunity
- Part VI Antiviral therapy
- Part VII Vaccines and immunothgerapy
- Part VIII Herpes as therapeutic agents
- Index
- Plate section
- References
Summary
Introduction
Cytomegaloviruses (CMVs) are ubiquitous but highly species specific agents and are a common cause of infections in many animal species including humans (Weller, 1971). The characteristic cellular changes caused by CMV including cell enlargement with intranuclear inclusions were first reported in 1881 by Ribbert in the kidneys of a stillborn infant with congenital syphilis (Ribbert, 1904). Subsequent reports have described similar findings in the parotid glands of children and in the salivary glands from guinea pigs. It was initially thought that cytomegalic inclusion disease (CID) of the newborn was the sole manifestation of human CMV (HCMV) infection (Goodpasture and Talbot, 1921; Lipschutz, 1921; Cole and Kuttner, 1926; Lowenstein, 1907). Several groups of investigators have simultaneously isolated and propagated HCMV from infants and children with CID and from adenoidal tissue of children undergoing adenoidectomy (Rowe et al., 1956; Smith, 1956; Weller et al., 1957). As tissue culture isolation and serological assays became more widely available, HCMV was linked to a variety of illnesses, many of which have subsequently been shown to be unrelated to HCMV. A common characteristic of patients at risk for invasive HCMV infections is the suppression of host immune responsiveness. The onset of AIDS epidemic in the early 1980s has led to a dramatic expansion of the spectrum of HCMV disease. HCMV was the most common opportunistic infection in patients with AIDS and a major cause of morbidity and mortality in these patients until the introduction of highly active antiretroviral therapy (Jacobson et al., 1988; Gallant et al., 1992; Munoz et al., 1993; Spector et al., 1999).
- Type
- Chapter
- Information
- Human HerpesvirusesBiology, Therapy, and Immunoprophylaxis, pp. 795 - 813Publisher: Cambridge University PressPrint publication year: 2007
References
- 18
- Cited by